Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

33.62
Delayed Data
As of Feb 17
 0.00 / 0.00%
Today’s Change
28.74
Today|||52-Week Range
37.39
+3.51%
Year-to-Date
May orders officials to examine Kraft Heinz's bid for Unilever
Feb 19 / FT.com - Paid Partner Content
Pfizer's Xeljanz Combo Comparable to AbbVie's Humira
Feb 17 / Zacks.com - Paid Partner Content
A Billionaire Recently Bought Pfizer Stock -- and So Did I
Feb 19 / MotleyFool.com - Paid Partner Content
Darrell & King Llc Buys Bank of Americaoration, Fluor, BB&T, Sells Cheesecake Factory...
Feb 17 / GuruFocus News - Paid Partner Content
Better Buy: Gilead Sciences, Inc. vs. Pfizer Inc.
Feb 18 / MotleyFool.com - Paid Partner Content
Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks
Feb 16 / MotleyFool.com - Paid Partner Content
The Best Investments for an IRA
Feb 18 / MotleyFool.com - Paid Partner Content
David Tepper Invests Heavily in Pharma in 4th Quarter
Feb 16 / GuruFocus News - Paid Partner Content
The Four Key Themes From Q4 Conference Calls
Feb 17 / Investing Channel - Paid Partner Content
How Bristol-Myers Squibb and Pfizer Are Winning a Big Brawl in Blood Thinners
Feb 16 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close33.62
Today’s open33.59
Day’s range33.53 - 33.89
Volume34,992,707
Average volume (3 months)26,940,660
Market cap$204.0B
Dividend yield3.81%
Data as of 4:01pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+5.09%
Earnings growth (this year)+6.97%
Earnings growth (next 5 years)+6.25%
Revenue growth (last year)+8.13%
P/E ratio33.6
Price/Sales3.79
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MRKMerck+0.13+0.20%
NVSNovartis+0.47+0.61%
SNYSanofi-0.38-0.87%
GSKGlaxoSmithKline+0.42+1.03%
Data as of 4:02pm ET, 02/17/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$0.67
Annual revenue (last year)$52.8B
Annual profit (last year)$7.2B
Net profit margin13.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts


Search for Jobs